Stockreport

Sandoz receives European Commission approval for Afqlir® (aflibercept), further strengthening leading biosimilar portfolio [Yahoo! Finance]

BAYER AG S/ADR  (BAYRY) 
NASDAQ:AMEX Investor Relations: investor.bayer.com
PDF One of several biosimilar value drivers for Sandoz Sandoz remains committed to accelerating patient access by strengthening its biosimilar portfolio, reinforcing glob [Read more]